CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: ceric oxide
Accession: CHEBI:79089
browse the term
Definition: A metal oxide with formula CeO2. It is used for polishing glass, in coatings for infra-red filters to prevent reflection, and as an oxidant and catalyst in organic synthesis.
Synonyms: exact_synonym: dioxocerium
related_synonym: CeO2; Formula=CeO2; InChI=1S/Ce.2O; InChIKey=CETPSERCERDGAM-UHFFFAOYSA-N; SMILES=O=[Ce]=O; ceria; ceric dioxide; cerium dioxide; cerium(4+) oxide; cerium(IV) oxide; cerium(IV)dioxide
xref: CAS:1306-38-3
xref_mesh: MESH:C030583
xref: PMID:21787599; PMID:24300997; Patent:US2564241; Reaxys:11323272; Reaxys:23048445; Wikipedia:Cerium(IV)_oxide
G
Akt1
AKT serine/threonine kinase 1
decreases expression
ISO
ceric oxide analog results in decreased expression of AKT1 mRNA
CTD
PMID:24821434
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Alb
albumin
decreases expression increases secretion affects expression
EXP ISO
ceric oxide results in decreased expression of ALB protein ceric oxide results in increased secretion of ALB protein ceric oxide affects the expression of ALB mRNA
CTD
PMID:22072870 PMID:23726862 PMID:29463257
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Ap3d1
adaptor related protein complex 3 subunit delta 1
decreases expression
ISO
ceric oxide analog results in decreased expression of AP3D1 mRNA
CTD
PMID:24821434
NCBI chr 7:8,970,249...9,005,651
Ensembl chr 7:8,970,291...9,005,643
G
Apaf1
apoptotic peptidase activating factor 1
increases expression
ISO
ceric oxide results in increased expression of APAF1 protein
CTD
PMID:24987704
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
ceric oxide results in increased expression of BAX protein
CTD
PMID:24987704
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
ceric oxide results in decreased expression of BCL2 protein
CTD
PMID:24987704
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Birc5
baculoviral IAP repeat-containing 5
increases expression
EXP
ceric oxide results in increased expression of BIRC5 mRNA
CTD
PMID:29463257
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
Brca1
BRCA1, DNA repair associated
decreases expression
EXP
ceric oxide results in decreased expression of BRCA1 mRNA
CTD
PMID:29463257
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
G
Casp3
caspase 3
increases cleavage increases expression
ISO
ceric oxide results in increased cleavage of CASP3 protein ceric oxide results in increased expression of CASP3 protein
CTD
PMID:24987704 PMID:26028148
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
affects expression
ISO
ceric oxide analog affects the expression of CASP7 mRNA
CTD
PMID:22960666
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Casp9
caspase 9
increases expression
ISO
ceric oxide results in increased expression of CASP9 protein
CTD
PMID:24987704
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
decreases activity multiple interactions affects expression
ISO EXP
ceric oxide results in decreased activity of CAT protein Acetylcysteine inhibits the reaction [ceric oxide results in decreased activity of CAT protein] ceric oxide affects the expression of CAT protein
CTD
PMID:20457660 PMID:23416263
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccl11
C-C motif chemokine ligand 11
multiple interactions increases expression
ISO EXP
[Antigens, Dermatophagoides co-treated with ceric oxide] results in decreased expression of CCL11 mRNA; [Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CCL11 protein; ceric oxide promotes the reaction [Antigens, Dermatophagoides results in increased expression of CCL11 mRNA] ceric oxide results in increased expression of CCL11 mRNA
CTD
PMID:29463257 PMID:29792201
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
G
Ccl17
C-C motif chemokine ligand 17
multiple interactions increases expression
ISO EXP
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CCL17 mRNA ceric oxide results in increased expression of CCL17 mRNA
CTD
PMID:29463257 PMID:29792201
NCBI chr19:10,202,128...10,203,903
Ensembl chr19:10,202,128...10,203,819
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions increases secretion increases expression
ISO EXP
[Antigens, Dermatophagoides co-treated with ceric oxide] results in decreased expression of CCL2 mRNA ceric oxide results in increased secretion of CCL2 protein ceric oxide results in increased expression of CCL2 mRNA
CTD
PMID:29463257 PMID:29792201
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl20
C-C motif chemokine ligand 20
multiple interactions affects expression
ISO EXP
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CCL20 mRNA ceric oxide affects the expression of CCL20 mRNA
CTD
PMID:29463257 PMID:29792201
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
Ccl22
C-C motif chemokine ligand 22
increases expression
EXP
ceric oxide results in increased expression of CCL22 mRNA
CTD
PMID:29463257
NCBI chr19:10,257,602...10,264,373
Ensembl chr19:10,257,601...10,264,400
G
Ccl24
C-C motif chemokine ligand 24
increases expression
EXP
ceric oxide results in increased expression of CCL24 mRNA
CTD
PMID:29463257
NCBI chr12:21,100,835...21,104,832
Ensembl chr12:21,100,835...21,104,893
G
Ccl26
C-C motif chemokine ligand 26
multiple interactions
ISO
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CCL26 mRNA
CTD
PMID:29792201
NCBI chr12:21,109,384...21,114,336
Ensembl chr12:21,109,421...21,114,335
G
Ccl3
C-C motif chemokine ligand 3
increases expression
EXP
ceric oxide results in increased expression of CCL3 mRNA
CTD
PMID:29463257
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccl4
C-C motif chemokine ligand 4
increases expression
EXP
ceric oxide results in increased expression of CCL4 mRNA
CTD
PMID:29463257
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Ccl7
C-C motif chemokine ligand 7
increases expression
EXP
ceric oxide results in increased expression of CCL7 mRNA
CTD
PMID:29463257
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
G
Ccr2
C-C motif chemokine receptor 2
increases expression
EXP
ceric oxide results in increased expression of CCR2 mRNA
CTD
PMID:29463257
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
G
Cd177
CD177 molecule
multiple interactions
ISO
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CD177 mRNA
CTD
PMID:29792201
NCBI chr 1:80,340,034...80,360,599
Ensembl chr 1:80,340,034...80,360,621
G
Cd40lg
CD40 ligand
decreases expression
EXP
ceric oxide results in decreased expression of CD40LG mRNA
CTD
PMID:29463257
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
G
Cd63
Cd63 molecule
increases expression
ISO
ceric oxide results in increased expression of CD63 protein
CTD
PMID:23726862
NCBI chr 7:1,325,108...1,340,447
Ensembl chr 7:1,325,103...1,399,178
G
Clca1
chloride channel accessory 1
multiple interactions
ISO
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CLCA1 mRNA [Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CLCA1 mRNA; ceric oxide promotes the reaction [Antigens, Dermatophagoides results in increased expression of CLCA1 protein]
CTD
PMID:29792201
NCBI chr 2:233,938,677...233,964,369
Ensembl chr 2:233,938,677...233,964,369
G
Clec10a
C-type lectin domain containing 10A
multiple interactions
ISO
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CLEC10A mRNA
CTD
PMID:29792201
NCBI chr10:54,876,244...54,880,439
Ensembl chr10:54,876,260...54,880,435
G
Cx3cl1
C-X3-C motif chemokine ligand 1
increases expression
EXP
ceric oxide results in increased expression of CX3CL1 mRNA
CTD
PMID:29463257
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
G
Cx3cr1
C-X3-C motif chemokine receptor 1
affects expression
EXP
ceric oxide affects the expression of CX3CR1 mRNA
CTD
PMID:29463257
NCBI chr 8:119,785,726...119,799,431
Ensembl chr 8:119,782,595...119,800,014
G
Cxcl10
C-X-C motif chemokine ligand 10
multiple interactions
ISO
ceric oxide inhibits the reaction [Antigens, Dermatophagoides results in increased expression of CXCL10 mRNA]
CTD
PMID:29792201
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl12
C-X-C motif chemokine ligand 12
decreases expression
EXP
ceric oxide results in decreased expression of CXCL12 mRNA
CTD
PMID:29463257
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
G
Cxcl9
C-X-C motif chemokine ligand 9
affects expression
EXP
ceric oxide affects the expression of CXCL9 mRNA
CTD
PMID:29463257
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
G
Cxcr2
C-X-C motif chemokine receptor 2
increases expression
EXP
ceric oxide results in increased expression of CXCR2 mRNA
CTD
PMID:29463257
NCBI chr 9:75,729,493...75,735,868
Ensembl chr 9:75,729,115...75,739,425
G
Cxcr3
C-X-C motif chemokine receptor 3
increases expression
EXP
ceric oxide results in increased expression of CXCR3 mRNA
CTD
PMID:29463257
NCBI chr X:66,844,318...66,846,969
Ensembl chr X:66,844,318...66,846,969
G
Cxcr5
C-X-C motif chemokine receptor 5
decreases expression
EXP
ceric oxide results in decreased expression of CXCR5 mRNA
CTD
PMID:29463257
NCBI chr 8:44,842,098...44,858,425
Ensembl chr 8:44,843,413...44,857,893
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions
ISO
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CYP1A1 mRNA
CTD
PMID:29792201
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
affects expression
EXP
ceric oxide affects the expression of CYP1B1 mRNA
CTD
PMID:29463257
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Dbnl
drebrin-like
decreases expression
ISO
ceric oxide analog results in decreased expression of DBNL mRNA
CTD
PMID:24821434
NCBI chr14:80,666,115...80,681,155
Ensembl chr14:80,666,124...80,681,155
G
Epx
eosinophil peroxidase
decreases expression
EXP
ceric oxide results in decreased expression of EPX mRNA
CTD
PMID:29463257
NCBI chr10:72,666,865...72,677,952
Ensembl chr10:72,666,865...72,677,952
G
Exo1
exonuclease 1
affects expression
EXP
ceric oxide affects the expression of EXO1 mRNA
CTD
PMID:29463257
NCBI chr13:87,809,725...87,834,654
Ensembl chr13:87,809,810...87,834,654
G
Fabp4
fatty acid binding protein 4
increases expression
EXP
ceric oxide results in increased expression of FABP4 mRNA
CTD
PMID:29463257
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
G
Gclc
glutamate-cysteine ligase, catalytic subunit
decreases expression
EXP
ceric oxide results in decreased expression of GCLC mRNA
CTD
PMID:29463257
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
decreases expression
EXP
ceric oxide results in decreased expression of GCLM mRNA
CTD
PMID:29463257
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Gpx2
glutathione peroxidase 2
decreases expression
EXP
ceric oxide results in decreased expression of GPX2 mRNA
CTD
PMID:29463257
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
G
Hba-a2
hemoglobin alpha, adult chain 2
decreases expression
EXP
ceric oxide results in decreased expression of HBA1 mRNA
CTD
PMID:29463257
NCBI chr10:15,323,830...15,324,677
Ensembl chr10:15,307,815...15,338,392 Ensembl chr10:15,307,815...15,338,392
G
Hfe
homeostatic iron regulator
decreases expression
ISO
ceric oxide analog results in decreased expression of HFE mRNA
CTD
PMID:24821434
NCBI chr17:41,413,451...41,421,502
Ensembl chr17:41,413,451...41,421,502
G
Hmox1
heme oxygenase 1
affects expression increases expression decreases expression multiple interactions
ISO
ceric oxide analog affects the expression of HMOX1 mRNA ceric oxide results in increased expression of HMOX1 protein ceric oxide results in decreased expression of HMOX1 mRNA ceric oxide inhibits the reaction [potassium bromate results in increased expression of HMOX1 mRNA]
CTD
PMID:19429248 PMID:22960666 PMID:25618551
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Id2
inhibitor of DNA binding 2
decreases expression
ISO
ceric oxide analog results in decreased expression of ID2 mRNA
CTD
PMID:24821434
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
G
Il13
interleukin 13
multiple interactions
ISO
ceric oxide inhibits the reaction [Antigens, Dermatophagoides results in increased expression of IL13 mRNA]
CTD
PMID:29792201
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il1a
interleukin 1 alpha
increases expression
EXP
ceric oxide results in increased expression of IL1A mRNA
CTD
PMID:29463257
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
increases expression
EXP
ceric oxide results in increased expression of IL1B mRNA; ceric oxide results in increased expression of IL1B protein
CTD
PMID:21624445 PMID:29463257
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
increases expression
EXP
ceric oxide results in increased expression of IL1RN mRNA
CTD
PMID:29463257
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il2rb
interleukin 2 receptor subunit beta
decreases expression
EXP
ceric oxide results in decreased expression of IL2RB mRNA
CTD
PMID:29463257
NCBI chr 7:110,033,341...110,048,054
Ensembl chr 7:110,033,341...110,048,054
G
Il2rg
interleukin 2 receptor subunit gamma
increases expression
EXP
ceric oxide results in increased expression of IL2RG mRNA
CTD
PMID:29463257
NCBI chr X:66,395,330...66,399,026
Ensembl chr X:66,392,542...66,399,823
G
Il4
interleukin 4
multiple interactions
ISO
ceric oxide promotes the reaction [Antigens, Dermatophagoides results in increased expression of IL4 mRNA]
CTD
PMID:29792201
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il6
interleukin 6
increases expression multiple interactions
EXP ISO
ceric oxide results in increased expression of IL6 protein [Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of IL6 mRNA
CTD
PMID:21624445 PMID:29792201
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Irf7
interferon regulatory factor 7
multiple interactions
ISO
ceric oxide inhibits the reaction [Antigens, Dermatophagoides results in increased expression of IRF7 mRNA]
CTD
PMID:29792201
NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832
G
Kif13b
kinesin family member 13B
increases expression
ISO
ceric oxide analog results in increased expression of KIF13B mRNA
CTD
PMID:24821434
NCBI chr15:38,908,257...39,066,021
Ensembl chr15:38,924,624...39,084,879
G
Kitlg
KIT ligand
increases expression
ISO
ceric oxide analog results in increased expression of KITLG mRNA
CTD
PMID:24821434
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
G
Lig4
DNA ligase 4
affects expression
EXP
ceric oxide affects the expression of LIG4 mRNA
CTD
PMID:29463257
NCBI chr16:79,518,393...79,526,956
Ensembl chr16:79,518,312...79,527,040
G
Lpo
lactoperoxidase
increases expression
EXP
ceric oxide results in increased expression of LPO mRNA; ceric oxide results in increased expression of LPO protein
CTD
PMID:29463257
NCBI chr10:72,606,950...72,626,220
Ensembl chr10:72,606,944...72,626,535
G
Mapk1
mitogen activated protein kinase 1
increases phosphorylation multiple interactions
ISO
ceric oxide results in increased phosphorylation of MAPK1 protein Acetylcysteine inhibits the reaction [ceric oxide results in increased phosphorylation of MAPK1 protein]
CTD
PMID:23416263
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions increases phosphorylation
ISO
Acetylcysteine inhibits the reaction [ceric oxide results in increased phosphorylation of MAPK3 protein]
CTD
PMID:23416263
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mmp12
matrix metallopeptidase 12
multiple interactions increases expression
ISO EXP
ceric oxide promotes the reaction [Antigens, Dermatophagoides results in increased expression of MMP12 mRNA] ceric oxide results in increased expression of MMP12 mRNA; ceric oxide results in increased expression of MMP12 protein
CTD
PMID:29463257 PMID:29792201
NCBI chr 8:4,581,785...4,591,687
Ensembl chr 8:4,581,785...4,599,611
G
Mmp9
matrix metallopeptidase 9
increases activity increases secretion
ISO
ceric oxide results in increased activity of MMP9 protein ceric oxide results in increased secretion of MMP9 protein
CTD
PMID:23726862
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mpo
myeloperoxidase
increases secretion increases expression
ISO EXP
ceric oxide results in increased secretion of MPO protein ceric oxide results in increased expression of MPO mRNA
CTD
PMID:23726862 PMID:29463257
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Msh5
mutS homolog 5
increases expression
EXP
ceric oxide results in increased expression of MSH5 mRNA
CTD
PMID:29463257
NCBI chr20:3,773,867...3,793,337
Ensembl chr20:3,776,942...3,793,336
G
Muc1
mucin 1, cell surface associated
multiple interactions
ISO
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of MUC1 mRNA
CTD
PMID:29792201
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
G
Muc5ac
mucin 5AC, oligomeric mucus/gel-forming
multiple interactions
ISO
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of MUC5AC mRNA
CTD
PMID:29792201
NCBI chr 1:196,864,336...196,896,475
Ensembl chr 1:196,864,336...196,896,475
G
Mutyh
mutY DNA glycosylase
decreases expression
EXP
ceric oxide results in decreased expression of MUTYH mRNA
CTD
PMID:29463257
NCBI chr 5:130,274,034...130,286,149
Ensembl chr 5:130,274,122...130,286,146
G
Ncf2
neutrophil cytosolic factor 2
increases expression decreases expression
EXP
ceric oxide results in increased expression of NCF2 mRNA ceric oxide results in decreased expression of NCF2 mRNA
CTD
PMID:29463257
NCBI chr13:64,955,622...64,986,144
Ensembl chr13:64,955,503...64,986,277
G
Nfe2l2
NFE2 like bZIP transcription factor 2
affects localization
ISO
ceric oxide affects the localization of NFE2L2 protein
CTD
PMID:19429248
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Ngb
neuroglobin
decreases expression
EXP
ceric oxide results in decreased expression of NGB mRNA
CTD
PMID:29463257
NCBI chr 6:106,744,378...106,749,830
Ensembl chr 6:106,744,378...106,749,830
G
Noxo1
NADPH oxidase organizer 1
increases expression
EXP
ceric oxide results in increased expression of NOXO1 mRNA
CTD
PMID:29463257
NCBI chr10:13,723,253...13,726,008
Ensembl chr10:13,721,473...13,726,061
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions
ISO
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of NQO1 mRNA
CTD
PMID:29792201
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Opcml
opioid binding protein/cell adhesion molecule-like
increases expression
EXP
ceric oxide results in increased expression of OPCML mRNA
CTD
PMID:29463257
NCBI chr 8:26,788,988...27,304,551
Ensembl chr 8:26,192,841...27,300,620
G
Osm
oncostatin M
affects expression
EXP
ceric oxide affects the expression of OSM mRNA
CTD
PMID:29463257
NCBI chr14:79,103,638...79,108,500
Ensembl chr14:79,104,344...79,108,313
G
Pf4
platelet factor 4
increases expression
EXP
ceric oxide results in increased expression of PF4 mRNA
CTD
PMID:29463257
NCBI chr14:17,298,304...17,299,220
Ensembl chr14:17,298,308...17,299,365
G
RT1-CE16
RT1 class I, locus CE16
decreases expression
ISO
ceric oxide analog results in decreased expression of HLA-A mRNA
CTD
PMID:24821434
NCBI chr20:3,257,109...3,260,747
Ensembl chr20:3,257,123...3,279,563
G
Scd
stearoyl-CoA desaturase
affects expression
EXP
ceric oxide affects the expression of SCD1 mRNA
CTD
PMID:29463257
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
G
Sectm1b
secreted and transmembrane 1B
decreases expression
ISO
ceric oxide analog results in decreased expression of SECTM1 mRNA
CTD
PMID:24821434
NCBI chr10:106,324,070...106,333,779
Ensembl chr10:106,325,203...106,333,769
G
Slc26a4
solute carrier family 26 member 4
multiple interactions
ISO
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of SLC26A4 mRNA [Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of SLC26A4 mRNA; ceric oxide promotes the reaction [Antigens, Dermatophagoides results in increased expression of SLC26A4 mRNA]
CTD
PMID:29792201
NCBI chr 6:48,107,575...48,153,762
Ensembl chr 6:48,107,588...48,145,703
G
Smug1
single-strand-selective monofunctional uracil-DNA glycosylase 1
increases expression
EXP
ceric oxide results in increased expression of SMUG1 mRNA
CTD
PMID:29463257
NCBI chr 7:134,288,565...134,302,179
Ensembl chr 7:134,287,675...134,297,226
G
Sod2
superoxide dismutase 2
multiple interactions increases expression
ISO
ceric oxide inhibits the reaction [potassium bromate results in increased expression of SOD2 mRNA] ceric oxide results in increased expression of SOD2 mRNA
CTD
PMID:25618551
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Spp1
secreted phosphoprotein 1
decreases expression
EXP
ceric oxide results in decreased expression of SPP1 mRNA
CTD
PMID:29463257
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Tafazzin
tafazzin, phospholipid-lysophospholipid transacylase
decreases expression
ISO
ceric oxide analog results in decreased expression of TAFAZZIN mRNA
CTD
PMID:24821434
NCBI chr X:152,065,539...152,076,178
Ensembl chr X:152,065,609...152,074,001
G
Tirap
TIR domain containing adaptor protein
decreases expression
ISO
ceric oxide analog results in decreased expression of TIRAP mRNA
CTD
PMID:24821434
NCBI chr 8:33,531,724...33,548,508
Ensembl chr 8:33,531,725...33,547,432
G
Tlr6
toll-like receptor 6
decreases expression
ISO
ceric oxide analog results in decreased expression of TLR6 mRNA
CTD
PMID:24821434
NCBI chr14:43,362,164...43,374,500
Ensembl chr14:43,362,164...43,375,685
G
Tnf
tumor necrosis factor
increases expression
EXP ISO
ceric oxide results in increased expression of TNF protein
CTD
PMID:21624445 PMID:27693598
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfsf4
TNF superfamily member 4
affects expression
EXP
ceric oxide affects the expression of TNFSF4 mRNA
CTD
PMID:29463257
NCBI chr13:73,723,329...73,746,809
Ensembl chr13:73,723,329...73,746,788
G
Tollip
toll interacting protein
decreases expression
ISO
ceric oxide analog results in decreased expression of TOLLIP mRNA
CTD
PMID:24821434
NCBI chr 1:196,961,585...196,984,252
Ensembl chr 1:196,950,771...196,983,625
G
Tp53
tumor protein p53
increases phosphorylation
ISO
ceric oxide results in increased phosphorylation of TP53 protein
CTD
PMID:24987704
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tslp
thymic stromal lymphopoietin
multiple interactions
ISO
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of TSLP mRNA
CTD
PMID:29792201
NCBI chr18:24,447,409...24,454,244
Ensembl chr18:24,449,844...24,453,548
G
Txnip
thioredoxin interacting protein
decreases expression
EXP
ceric oxide results in decreased expression of TXNIP mRNA
CTD
PMID:29463257
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all